doi: 10.7861/clinmedicine.15-1-54
Clin Med February 1, 2015 vol. 15 no. 1 54-57
This guidance aims to support national clusters to implement their commitments on AAP and core people-related issues both before the beginning of a response (preparedness) and thereafter, throughout the Humanitarian Programme Cycle (HPC)
Despite the stated centrality of protection in humanitarian action and a growing attention to protection activities, the evaluation of protection has received relatively little attention. This pilot guide seeks to fill this gap, providing insights and guidance to those evaluating protection in the c...ontext of humanitarian action
more
Source: 1,981 listener groups, engaging 9,281 individuals, conducted by IOM,
Bangladesh Betar and ACF from August to November 2018. This feedback was
collected from camps 1, 2, 10, 11, 15, 16, 19, 22, 23, 24 and 25. Listener groups included
an even spread of men, women, adults and children and ar...ound 10% of participants
were particularly vulnerable (pregnant women, lactating mothers, older people and
people with disabilities). In addition, focus group discussions were conducted in camp
24 to explore these issues in more depth.
more
A Technical Paper. Final Report
Submitted to The Lesotho National Federation of Disabled (LNFOD)
This journal is funded by CBM
World Drug Report 2018
-2-
World Drug Report 2018
-4-
Yemen remains the world’s worst humanitarian crisis with staggering levels of humanitarian need. Eighty per cent of the population – 24.1 million people – need some form of humanitarian assistance. Economic decline, restrictions on imports, shortages of foreign exchange and liquidity, and fluc...tuations in the value of the currency continues to put millions of people at risk of famine. Key assessments remain blocked, complicating efforts to adjust programmes based on the latest evidence. This makes it difficult to know with certainty whether there are large pockets of unmet needs across the country.
more
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...control during the past decade has prompted increasing global dialogue on its elimination and eradication. The disease is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2020 and to terminate its transmission globally by 2030, along-side other Neglected Tropical Diseases (NTD). Several methods have been used to control tsetse flies and the disease transmitted by them. Old and new tools to control the disease are available with constraints.
Currently, there are no vaccines available. Efforts towards intervention to control the disease over the past decade have seen considerable progress and remarkable success with incidence dropping progressively, reversing the upward trend of reported cases. This gives credence in a real progress in its elimination. This study reviews various control measures, progress and a highlight of control issues, vector and parasite barriers that may have been hindering progress towards its elimination.
more
The war has not only triggered the largest movement of refugees in Europe since the end of the Second World War.
Its manifold effects can be seen worldwide: forexample, consumer prices have risen and, in view of blocked grain exports of wheat, barley, and maize, food security in Africa is at risk. ...This issue brief summarizes the impact the conflict has and had on global food security.
more
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...tems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
more